Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

Clinical trial NCT05040373 · RECRUITING

Trial details

NCT number: NCT05040373
Sponsor: Alnylam Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Hereditary Transthyretin-mediated (hATTR) Amyloidosis Polyneuropathy

Start date: 2020-08-01
Primary completion: 2030-10-12
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.